Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases like ulcerative colitis. Read the pre-IPO report here.
KOCHI: Inflammation, a critical process for the body’s defence and tissue repair, is an essential part of our immune system. It is activated in response to infe ...